These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
4. Leveraging the cortical cholinergic system to enhance attention. Demeter E; Sarter M Neuropharmacology; 2013 Jan; 64(1):294-304. PubMed ID: 22796110 [TBL] [Abstract][Full Text] [Related]
5. PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. McLean SL; Idris NF; Grayson B; Gendle DF; Mackie C; Lesage AS; Pemberton DJ; Neill JC J Psychopharmacol; 2012 Sep; 26(9):1265-70. PubMed ID: 22182741 [TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Drew AE; Derbez AE; Werling LL Synapse; 2000 Oct; 38(1):10-6. PubMed ID: 10941136 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of modafinil on emotional memory in mice. Fernandes HA; Zanin KA; Patti CL; Wuo-Silva R; Carvalho RC; Fernandes-Santos L; Bittencourt LR; Tufik S; Frussa-Filho R Neuropharmacology; 2013 Jan; 64():365-70. PubMed ID: 22771974 [TBL] [Abstract][Full Text] [Related]
11. Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. Kholdebarin E; Caldwell DP; Blackwelder WP; Kao M; Christopher NC; Levin ED Eur J Pharmacol; 2007 Aug; 569(1-2):64-9. PubMed ID: 17544392 [TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. Rezvani AH; Caldwell DP; Levin ED Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917 [TBL] [Abstract][Full Text] [Related]
13. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task. Wood C; Kohli S; Malcolm E; Allison C; Shoaib M Neuropharmacology; 2016 Jun; 105():106-113. PubMed ID: 26772970 [TBL] [Abstract][Full Text] [Related]
14. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia. Hahn B; Gold JM; Buchanan RW Neuropharmacology; 2013 Jan; 64():185-90. PubMed ID: 22705396 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893 [TBL] [Abstract][Full Text] [Related]
16. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. Nikiforuk A; Popik P; Drescher KU; van Gaalen M; Relo AL; Mezler M; Marek G; Schoemaker H; Gross G; Bespalov A J Pharmacol Exp Ther; 2010 Dec; 335(3):665-73. PubMed ID: 20739457 [TBL] [Abstract][Full Text] [Related]
17. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718 [TBL] [Abstract][Full Text] [Related]